“Basal+cell+carcinoma”的搜索结果，显示 101-110 项，共有 5155 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...

2. 神经科- 临床试验- 妙佑医疗国际

   Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Pagination 临床研究. Prev ...

3. 神经科- 临床试验- 妙佑医疗国际

   Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Pagination 临床研究. Prev ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in ...

5. 痣 - 医生与科室- 妙佑医疗国际

   ... Skin cancer, Squamous cell carcinoma of the skin, Merkel cell carcinoma, Basal cell carcinoma, Dermatofibrosarcoma protuberans, Gorlin syndrome, Epidermoid cyst ...

6. 神经科- 临床试验- 妙佑医疗国际

   Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Pagination 临床研究. Prev ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... tumor may kill more tumor cells and cause less damage to normal tissue. ... cancer (TNBC) or non-small cell lung cancer (NSCLC). The first part of the ...

8. 外科 - 临床试验- 妙佑医疗国际

   This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... tumor may kill more tumor cells and cause less damage to normal tissue. ... cancer (TNBC) or non-small cell lung cancer (NSCLC). The first part of the ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work ...